ArticleJournal of thoracic disease2025
The diagnostic implications of the pleural fluid cell differentiation.
Article in Journal of thoracic disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Pleural fluid cell differentiation is recommended as an initial investigation of undiagnosed unilateral pleural effusions along with routine biochemical, microbiological, and cytological analysis. However, the sensitivity and specificity of cell differentiation from initial pleural aspiration remains unknown. As such, this study aimed to establish the value of pleural cell differentiation in the investigation of undiagnosed pleural effusions. Methods: We performed a prospective study of 1,023 patients presenting to a UK tertiary pleural service with an undiagnosed unilateral pleural effusion between December 2008 and December 2016. Twenty-six patients were excluded due to incomplete data and unclear diagnoses, leaving 997 for analysis. Two respiratory consultants confirmed the diagnosis at 12 months. Cell differentiation was defined according to the British Thoracic Society (BTS) guidelines. Results: The median age of the cohort was 73 years [95% confidence interval (CI): 71-74 years]. Of the 997 patients, 532 (53.4%) were found to have a malignant aetiology and 465 (46.7%) were non-malignant. On review of the pleural fluid cytology, 423 were mixed (42.4%) with no predominant cell type, 352 were lymphocytic (35.3%), 95 were neutrophilic (9.5%), 72 were eosinophilic (7.2%), and 55 were blood-stained (5.5%). Of the lymphocytic effusions, 53.7% had malignant aetiology. A lymphocyte predominance had a sensitivity of 35.5% (95% CI: 31.5-39.8%) and specificity of 65.0% (95% CI: 60.4-69.3%) for malignancy. The majority (80%) of neutrophilic effusions had infectious aetiology with a positive likelihood ratio of 20.6 (95% CI: 12.8-33.1), however, 14% of cases (13/95) had a final diagnosis of malignancy. Of the eosinophilic effusions, 43.0% were also of malignant aetiology, with a positive likelihood ratio of 0.66 (95% CI: 0.42-1.04). Conclusions: This study demonstrated that pleural fluid cell differentiation has limited diagnostic value. Although it may guide towards the likely diagnosis, it lacks diagnostic accuracy as a rule-in/out test and should be used cautiously by clinicians.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.